Could a Two-Drug combo finally tame overactive bladder?
NCT ID NCT07429734
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study tests whether adding gabapentin to the standard drug solifenacin works better than solifenacin alone for women with overactive bladder. Sixty women will be randomly assigned to one of the two treatments and followed for 3 months. The goal is to see if the combination improves bladder symptoms and is safe.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- Active substance
- solifenacin and gabapentin
- What this could lead to
- If it works, this could offer a more effective drug combination to ease overactive bladder symptoms in women.
- What could go wrong
- This is a small early-stage trial with only 60 participants. The combination may not work better than the standard drug alone, and gabapentin can cause side effects like dizziness or drowsiness.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for OVERACTIVE BLADDER are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Urology and Nephrology center - Mansoura University
Al Mansurah, Egypt
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Diabetes drug class may change how the bladder behaves
- Botox vs. blood plasma: which works better for a bladder that Won't quit?
- Vibrating device aims to restore bladder control in cancer survivors
- Ankle nerve zap may ease Kids' bladder troubles
- Could a Take-Home antibiotic prescription cut unnecessary ER visits after bladder botox?
- Could probiotics calm your bladder and your anxiety?